TreeWAS – Variant ID: rs7928758

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Y83.1 Surgical operation with implant of artificial internal device	0.104	0.896	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.082	0.918	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.079	0.921	0.000
C82.0 Small cleaved cell, follicular	0.068	0.932	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.067	0.933	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.066	0.934	0.000
C91 Lymphoid leukaemia	0.063	0.937	0.000
C82.3 Follicular lymphoma grade IIIa	0.062	0.937	0.000
C82.4 Follicular lymphoma grade IIIb	0.060	0.940	0.000
C91.1 Chronic lymphocytic leukaemia	0.059	0.941	0.000
C82.2 Large cell, follicular	0.057	0.943	0.000
C81 Hodgkin's disease	0.057	0.943	0.000
C82.6 Cutaneous follicle centre lymphoma	0.057	0.943	0.000
C82.5 Diffuse follicle centre lymphoma	0.057	0.943	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.056	0.944	0.000
T39.0 Salicylates	0.054	0.946	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.054	0.946	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.053	0.947	0.000
C91.9 Lymphoid leukaemia, unspecified	0.053	0.947	0.000
C91.4 Hairy-cell leukaemia	0.052	0.947	0.000
C88 Malignant immunoproliferative diseases	0.052	0.948	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.052	0.948	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.051	0.949	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.050	0.950	0.000
T43.2 Other and unspecified antidepressants	0.050	0.950	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.049	0.951	0.000
C86 Other specified types of T/NK-cell lymphoma	0.049	0.951	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.048	0.952	0.000
C94 Other leukaemias of specified cell type	0.048	0.952	0.000
C93 Monocytic leukaemia	0.048	0.952	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.047	0.953	0.000
C81.1 Nodular sclerosis	0.047	0.953	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.046	0.954	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.046	0.954	0.000
C91.7 Other lymphoid leukaemia	0.046	0.954	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.046	0.954	0.000
C91.5 Adult T-cell leukaemia	0.046	0.954	0.000
C91.3 Prolymphocytic leukaemia	0.046	0.954	0.000
C91.2 Subacute lymphocytic leukaemia	0.046	0.954	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.045	0.955	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.045	0.955	0.000
C81.2 Mixed cellularity	0.044	0.955	0.000
C81.9 Hodgkin's disease, unspecified	0.044	0.956	0.000
C92 Myeloid leukaemia	0.044	0.956	0.000
T39.1 4-Aminophenol derivatives	0.044	0.956	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.044	0.956	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.043	0.957	0.000
C95 Leukaemia of unspecified cell type	0.042	0.958	0.000
C81.7 Other Hodgkin's disease	0.041	0.959	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.041	0.959	0.000
C81.3 Lymphocytic depletion	0.041	0.959	0.000
C81.0 Lymphocytic predominance	0.041	0.959	0.000
C84.0 Mycosis fungoides	0.041	0.959	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.041	0.959	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.040	0.959	0.000
T43.9 Psychotropic drug, unspecified	0.040	0.960	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.040	0.960	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.040	0.960	0.000
C84.5 Other and unspecified T-cell lymphomas	0.040	0.960	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.039	0.960	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.039	0.961	0.000
T39.4 Antirheumatics, not elsewhere classified	0.039	0.961	0.000
T39.2 Pyrazolone derivatives	0.039	0.961	0.000
C90.2 Plasmacytoma, extramedullary	0.039	0.961	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.038	0.961	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.038	0.961	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.038	0.961	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.038	0.961	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.038	0.961	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.038	0.962	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.038	0.962	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.038	0.962	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.038	0.962	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.038	0.962	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.038	0.962	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.037	0.963	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.037	0.963	0.000
C88.7 Other malignant immunoproliferative diseases	0.037	0.963	0.000
C88.3 Immunoproliferative small intestinal disease	0.037	0.963	0.000
C88.2 Gamma heavy chain disease	0.037	0.963	0.000
C88.1 Alpha heavy chain disease	0.037	0.963	0.000
C91.0 Acute lymphoblastic leukaemia	0.037	0.963	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.037	0.963	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.037	0.963	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.037	0.963	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.037	0.963	0.000
C84.3 Lymphoepithelioid lymphoma	0.037	0.963	0.000
C84.2 T-zone lymphoma	0.037	0.963	0.000
C84.1 Sezary's diease	0.037	0.963	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.036	0.964	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.036	0.964	0.000
T47.0 Histamine H(2)-receptor antagonists	0.035	0.964	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.035	0.965	0.000
C86.4 Blastic NK-cell lymphoma	0.035	0.965	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.035	0.965	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.035	0.965	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.035	0.965	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.035	0.965	0.000
C92.4 Acute promyelocytic leukaemia	0.034	0.965	0.000
C93.9 Monocytic leukaemia, unspecified	0.034	0.965	0.000
C93.7 Other monocytic leukaemia	0.034	0.965	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.034	0.965	0.000
C93.2 Subacute monocytic leukaemia	0.034	0.965	0.000
C93.1 Chronic monocytic leukaemia	0.034	0.965	0.000
C93.0 Acute monocytic leukaemia	0.034	0.965	0.000
C94.7 Other specified leukaemias	0.034	0.965	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.034	0.965	0.000
C94.5 Acute myelofibrosis	0.034	0.965	0.000
C94.4 Acute panmyelosis	0.034	0.965	0.000
C94.3 Mast cell leukaemia	0.034	0.965	0.000
C94.2 Acute megakaryoblastic leukaemia	0.034	0.965	0.000
C94.1 Chronic erythraemia	0.034	0.965	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.034	0.965	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.034	0.965	0.000
C96.8 Histiocytic sarcoma	0.034	0.965	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.034	0.965	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.034	0.965	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.034	0.965	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.034	0.965	0.000
C96.3 True histiocytic lymphoma	0.034	0.965	0.000
C96.2 Malignant mast cell tumour	0.034	0.965	0.000
C96.1 Malignant histiocytosis	0.034	0.965	0.000
C96.0 Letterer-Siwe disease	0.034	0.965	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.034	0.966	0.000
C90.3 Solitary plasmacytoma	0.034	0.966	0.000
C90.1 Plasma cell leukaemia	0.034	0.966	0.000
T36 Poisoning by systemic antibiotics	0.034	0.966	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.034	0.966	0.000
T43.6 Psychostimulants with abuse potential	0.033	0.967	0.000
C85.1 B-cell lymphoma, unspecified	0.033	0.967	0.000
T42.0 Hydantoin derivatives	0.033	0.967	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.033	0.967	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.033	0.967	0.000
C92.1 Chronic myeloid leukaemia	0.033	0.967	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.032	0.968	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.032	0.968	0.000
T42.3 Barbiturates	0.032	0.968	0.000
T42.2 Succinimides and oxazolidinediones	0.032	0.968	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.032	0.968	0.000
C85.0 Lymphosarcoma	0.032	0.968	0.000
T42.4 Benzodiazepines	0.032	0.968	0.000
T40.2 Other opioids	0.032	0.968	0.000
C84.4 Peripheral T-cell lymphoma	0.032	0.968	0.000
C92.9 Myeloid leukaemia, unspecified	0.032	0.968	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.032	0.968	0.000
C92.7 Other myeloid leukaemia	0.032	0.968	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.032	0.968	0.000
C92.5 Acute myelomonocytic leukaemia	0.032	0.968	0.000
C92.3 Myeloid sarcoma	0.032	0.968	0.000
C92.2 Subacute myeloid leukaemia	0.032	0.968	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.031	0.968	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.031	0.968	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.031	0.968	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.031	0.968	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.031	0.968	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.031	0.968	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.031	0.968	0.000
T44.0 Anticholinesterase agents	0.031	0.968	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.031	0.969	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.031	0.969	0.000
T47.7 Emetics	0.031	0.969	0.000
T47.6 Antidiarrhoeal drugs	0.031	0.969	0.000
T47.5 Digestants	0.031	0.969	0.000
T47.4 Other laxatives	0.031	0.969	0.000
T47.3 Saline and osmotic laxatives	0.031	0.969	0.000
T47.2 Stimulant laxatives	0.031	0.969	0.000
C95.7 Other leukaemia of unspecified cell type	0.030	0.969	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.030	0.969	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.030	0.969	0.000
C95.0 Acute leukaemia of unspecified cell type	0.030	0.969	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.030	0.970	0.000
T46.1 Calcium-channel blockers	0.030	0.970	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.030	0.970	0.000
T38.1 Thyroid hormones and substitutes	0.030	0.970	0.000
C83.3 Large cell (diffuse)	0.030	0.970	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.029	0.970	0.000
T38.9 Other and unspecified hormone antagonists	0.029	0.970	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.029	0.970	0.000
T38.7 Androgens and anabolic congeners	0.029	0.970	0.000
T38.5 Other oestrogens and progestogens	0.029	0.970	0.000
T38.4 Oral contraceptives	0.029	0.970	0.000
T38.2 Antithyroid drugs	0.029	0.970	0.000
T38.0 Glucocorticoids and synthetic analogues	0.029	0.970	0.000
C83.1 Small cleaved cell (diffuse)	0.029	0.970	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.029	0.971	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.028	0.972	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.028	0.972	0.000
T37.5 Antiviral drugs	0.028	0.972	0.000
T37.4 Anthelminthics	0.028	0.972	0.000
T37.3 Other antiprotozoal drugs	0.028	0.972	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.028	0.972	0.000
T37.1 Antimycobacterial drugs	0.028	0.972	0.000
T37.0 Sulphonamides	0.028	0.972	0.000
T41.5 Therapeutic gases	0.028	0.972	0.000
T41.4 Anaesthetic, unspecified	0.028	0.972	0.000
T41.3 Local anaesthetics	0.028	0.972	0.000
T41.2 Other and unspecified general anaesthetics	0.028	0.972	0.000
T41.1 Intravenous anaesthetics	0.028	0.972	0.000
T41.0 Inhaled anaesthetics	0.028	0.972	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.028	0.972	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.028	0.972	0.000
T48.5 Anti-common-cold drugs	0.028	0.972	0.000
T48.4 Expectorants	0.028	0.972	0.000
T48.3 Antitussives	0.028	0.972	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.028	0.972	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.028	0.972	0.000
T48.0 Oxytocic drugs	0.028	0.972	0.000
T49.9 Topical agent, unspecified	0.028	0.972	0.000
T49.8 Other topical agents	0.028	0.972	0.000
T49.7 Dental drugs, topically applied	0.028	0.972	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.028	0.972	0.000
T49.5 Ophthalmological drugs and preparations	0.028	0.972	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.028	0.972	0.000
T49.3 Emollients, demulcents and protectants	0.028	0.972	0.000
T49.2 Local astringents and local detergents	0.028	0.972	0.000
T49.1 Antipruritics	0.028	0.972	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.028	0.972	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.028	0.972	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.028	0.972	0.000
T46.7 Peripheral vasodilators	0.028	0.972	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.028	0.972	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.028	0.972	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.028	0.972	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.028	0.972	0.000
T40.8 Lysergide [LSD]	0.028	0.972	0.000
T40.7 Cannabis (derivatives)	0.028	0.972	0.000
T40.5 Cocaine	0.028	0.972	0.000
T40.3 Methadone	0.028	0.972	0.000
T40.1 Heroin	0.028	0.972	0.000
T40.0 Opium	0.028	0.972	0.000
T42.1 Iminostilbenes	0.027	0.973	0.000
C83.6 Undifferentiated (diffuse)	0.027	0.973	0.000
C83.5 Lymphoblastic (diffuse)	0.027	0.973	0.000
C83.4 Immunoblastic (diffuse)	0.027	0.973	0.000
C83.2 Mixed small and large cell (diffuse)	0.027	0.973	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.027	0.973	0.000
T40.6 Other and unspecified narcotics	0.027	0.973	0.000
C83.7 Burkitt's tumour	0.026	0.974	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.026	0.974	0.000
C83.0 Small cell (diffuse)	0.026	0.974	0.000
C90.0 Multiple myeloma	0.026	0.974	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.025	0.974	0.000
S52.50 Fracture of lower end of radius (closed)	0.000	0.974	0.026
C95.9 Leukaemia, unspecified	0.025	0.975	0.000
C18.0 Caecum	0.025	0.975	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.025	0.975	0.000
T50.8 Diagnostic agents	0.025	0.975	0.000
T50.7 Analeptics and opioid receptor antagonists	0.025	0.975	0.000
T50.5 Appetite depressants	0.025	0.975	0.000
T50.4 Drugs affecting uric acid metabolism	0.025	0.975	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.025	0.975	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.025	0.975	0.000
T50.1 Loop [high-ceiling] diuretics	0.025	0.975	0.000
T50.0 Mineralocorticoids and their antagonists	0.025	0.975	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.025	0.975	0.000
T36.9 Systemic antibiotic, unspecified	0.024	0.975	0.000
T36.8 Other systemic antibiotics	0.024	0.975	0.000
T36.7 Antifungal antibiotics, systemically used	0.024	0.975	0.000
T36.6 Rifamycins	0.024	0.975	0.000
T36.5 Aminoglycosides	0.024	0.975	0.000
T36.4 Tetracyclines	0.024	0.975	0.000
T36.3 Macrolides	0.024	0.975	0.000
T36.2 Chloramphenicol group	0.024	0.975	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.024	0.975	0.000
C18.6 Descending colon	0.025	0.975	0.000
T45.2 Vitamins, not elsewhere classified	0.024	0.976	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.024	0.976	0.000
T45.8 Other primarily systemic and haematological agents	0.024	0.976	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.024	0.976	0.000
T45.6 Fibrinolysis-affecting drugs	0.024	0.976	0.000
T45.4 Iron and its compounds	0.024	0.976	0.000
T45.3 Enzymes, not elsewhere classified	0.024	0.976	0.000
C18 Malignant neoplasm of colon	0.023	0.977	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.023	0.977	0.000
T40.4 Other synthetic narcotics	0.021	0.979	0.000
C18.7 Sigmoid colon	0.021	0.979	0.000
C92.0 Acute myeloid leukaemia	0.021	0.979	0.000
T45.5 Anticoagulants	0.021	0.979	0.000
T36.0 Penicillins	0.020	0.980	0.000
C18.5 Splenic flexure	0.019	0.981	0.000
T45.0 Antiallergic and antiemetic drugs	0.019	0.981	0.000
C18.8 Overlapping lesion of colon	0.018	0.982	0.000
C77.2 Intra-abdominal lymph nodes	0.017	0.983	0.000
C18.4 Transverse colon	0.017	0.983	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.016	0.983	0.000
C15 Malignant neoplasm of oesophagus	0.017	0.983	0.000
C15-C26 Malignant neoplasms of digestive organs	0.016	0.984	0.000
C15.4 Middle third of oesophagus	0.015	0.985	0.000
C15.5 Lower third of oesophagus	0.015	0.985	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.014	0.985	0.000
E11.3 With ophthalmic complications	0.014	0.986	0.000
C15.3 Upper third of oesophagus	0.014	0.986	0.000
S52.5 Fracture of lower end of radius	0.000	0.986	0.014
E11 Non-insulin-dependent diabetes mellitus	0.014	0.986	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.014	0.986	0.000
C43 Malignant melanoma of skin	0.014	0.986	0.000
S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level	0.013	0.987	0.000
C18.1 Appendix	0.013	0.987	0.000
C24.0 Extrahepatic bile duct	0.013	0.987	0.000
E11.4 With neurological complications	0.013	0.987	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.013	0.987	0.000
C18.9 Colon, unspecified	0.013	0.987	0.000
E11.5 With peripheral circulatory complications	0.013	0.987	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.013	0.987	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.013	0.987	0.000
C15.9 Oesophagus, unspecified	0.013	0.987	0.000
C77.1 Intrathoracic lymph nodes	0.013	0.987	0.000
E11.2 With renal complications	0.012	0.988	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.012	0.988	0.000
D03.5 Melanoma in situ of trunk	0.012	0.988	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.012	0.988	0.000
C77.5 Intrapelvic lymph nodes	0.012	0.988	0.000
C18.3 Hepatic flexure	0.012	0.988	0.000
C15.8 Overlapping lesion of oesophagus	0.012	0.988	0.000
C15.2 Abdominal part of oesophagus	0.012	0.988	0.000
C15.1 Thoracic part of oesophagus	0.012	0.988	0.000
C15.0 Cervical part of oesophagus	0.012	0.988	0.000
C43.5 Malignant melanoma of trunk	0.012	0.988	0.000
Chapter II Neoplasms	0.012	0.988	0.000
C21 Malignant neoplasm of anus and anal canal	0.012	0.988	0.000
C77.9 Lymph node, unspecified	0.012	0.988	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.011	0.989	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.011	0.989	0.000
C24.9 Biliary tract, unspecified	0.011	0.989	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.011	0.989	0.000
S52.51 Fracture of lower end of radius (open)	0.000	0.989	0.011
C24.1 Ampulla of Vater	0.011	0.989	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.011	0.989	0.000
C17 Malignant neoplasm of small intestine	0.011	0.989	0.000
C79 Secondary malignant neoplasm of other sites	0.011	0.989	0.000
C24.8 Overlapping lesion of biliary tract	0.011	0.989	0.000
C16 Malignant neoplasm of stomach	0.011	0.989	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.011	0.989	0.000
E11.6 With other specified complications	0.010	0.989	0.000
D03 Melanoma in situ	0.010	0.990	0.000
C22.9 Liver, unspecified	0.010	0.990	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.010	0.990	0.000
E11.9 Without complications	0.010	0.990	0.000
C23 Malignant neoplasm of gallbladder	0.010	0.990	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.010	0.990	0.000
E11.7 With multiple complications	0.010	0.990	0.000
C43.8 Overlapping malignant melanoma of skin	0.010	0.990	0.000
C43.0 Malignant melanoma of lip	0.010	0.990	0.000
C77.8 Lymph nodes of multiple regions	0.010	0.990	0.000
E11.8 With unspecified complications	0.010	0.990	0.000
C43.4 Malignant melanoma of scalp and neck	0.010	0.990	0.000
C76.0 Head, face and neck	0.010	0.990	0.000
C18.2 Ascending colon	0.010	0.990	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.009	0.990	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.009	0.991	0.000
E11.0 With coma	0.009	0.991	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.009	0.991	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.009	0.991	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.009	0.991	0.000
C16.0 Cardia	0.009	0.991	0.000
C22.7 Other specified carcinomas of liver	0.009	0.991	0.000
C22.4 Other sarcomas of liver	0.009	0.991	0.000
C22.3 Angiosarcoma of liver	0.009	0.991	0.000
C22.2 Hepatoblastoma	0.009	0.991	0.000
C22.0 Liver cell carcinoma	0.009	0.991	0.000
C76.1 Thorax	0.009	0.991	0.000
E11.1 With ketoacidosis	0.009	0.991	0.000
C80 Malignant neoplasm without specification of site	0.009	0.991	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.009	0.991	0.000
C17.2 Ileum	0.009	0.991	0.000
C21.1 Anal canal	0.009	0.991	0.000
C26.9 Ill-defined sites within the digestive system	0.009	0.991	0.000
C21.2 Cloacogenic zone	0.008	0.991	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.008	0.991	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.008	0.991	0.000
C78.2 Secondary malignant neoplasm of pleura	0.000	0.991	0.008
C26.8 Overlapping lesion of digestive system	0.008	0.992	0.000
C26.1 Spleen	0.008	0.992	0.000
C43.9 Malignant melanoma of skin, unspecified	0.008	0.992	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.008	0.992	0.000
C16.6 Greater curvature of stomach, unspecified	0.008	0.992	0.000
C17.1 Jejunum	0.008	0.992	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.008	0.992	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.008	0.992	0.000
C76.7 Other ill-defined sites	0.008	0.992	0.000
C76.5 Lower limb	0.008	0.992	0.000
C76.4 Upper limb	0.008	0.992	0.000
C17.8 Overlapping lesion of small intestine	0.008	0.992	0.000
C17.3 Meckel's diverticulum	0.008	0.992	0.000
D03.7 Melanoma in situ of lower limb, including hip	0.008	0.992	0.000
C22.1 Intrahepatic bile duct carcinoma	0.008	0.992	0.000
S66 Injury of muscle and tendon at wrist and hand level	0.008	0.992	0.000
C16.8 Overlapping lesion of stomach	0.008	0.992	0.000
C16.4 Pylorus	0.008	0.992	0.000
C16.1 Fundus of stomach	0.008	0.992	0.000
C76.2 Abdomen	0.008	0.992	0.000
D00-D09 In situ neoplasms	0.008	0.992	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.008	0.992	0.000
C97 Malignant neoplasms of independent (primary) multiple sites	0.008	0.992	0.000
D03.9 Melanoma in situ, unspecified	0.008	0.992	0.000
D03.8 Melanoma in situ of other sites	0.008	0.992	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.008	0.992	0.000
D03.0 Melanoma in situ of lip	0.008	0.992	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.008	0.992	0.000
C17.9 Small intestine, unspecified	0.007	0.992	0.000
C16.5 Lesser curvature of stomach, unspecified	0.008	0.992	0.000
C21.0 Anus, unspecified	0.007	0.992	0.000
C16.2 Body of stomach	0.007	0.992	0.000
C26.0 Intestinal tract, part unspecified	0.007	0.992	0.000
C76.3 Pelvis	0.007	0.992	0.000
S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level	0.007	0.993	0.000
C60-C63 Malignant neoplasms of male genital organs	0.007	0.993	0.000
C79.6 Secondary malignant neoplasm of ovary	0.007	0.993	0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.007	0.993	0.000
C16.3 Pyloric antrum	0.007	0.993	0.000
D03.4 Melanoma in situ of scalp and neck	0.007	0.993	0.000
O20.0 Threatened abortion	0.000	0.993	0.007
C77.4 Inguinal and lower limb lymph nodes	0.007	0.993	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.007	0.993	0.000
S66.9 Injury of unspecified muscle and tendon at wrist and hand level	0.007	0.993	0.000
Z95.3 Presence of xenogenic heart valve	0.007	0.993	0.000
C62 Malignant neoplasm of testis	0.007	0.993	0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.007	0.993	0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.007	0.993	0.000
C74 Malignant neoplasm of adrenal gland	0.007	0.993	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.007	0.993	0.000
C51-C58 Malignant neoplasms of female genital organs	0.007	0.993	0.000
C79.2 Secondary malignant neoplasm of skin	0.006	0.993	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.007	0.993	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.006	0.993	0.000
S66.0 Injury of long flexor muscle and tendon of thumb at wrist and hand level	0.006	0.994	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.006	0.994	0.000
C55 Malignant neoplasm of uterus, part unspecified	0.006	0.994	0.000
C62.9 Testis, unspecified	0.006	0.994	0.000
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.006	0.994	0.000
C25 Malignant neoplasm of pancreas	0.006	0.994	0.000
C17.0 Duodenum	0.006	0.994	0.000
C41.4 Pelvic bones, sacrum and coccyx	0.006	0.994	0.000
H36.0 Diabetic retinopathy	0.006	0.994	0.000
N60.4 Mammary duct ectasia	0.006	0.994	0.000
S66.5 Injury of intrinsic muscle and tendon of other finger at wrist and hand level	0.006	0.994	0.000
S66.4 Injury of intrinsic muscle and tendon of thumb at wrist and hand level	0.006	0.994	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.006	0.994	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.006	0.994	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.006	0.994	0.000
C41.1 Mandible	0.005	0.994	0.000
C52 Malignant neoplasm of vagina	0.006	0.994	0.000
C63 Malignant neoplasm of other and unspecified male genital organs	0.005	0.994	0.000
C80.9 Malignant neoplasm, unspecified	0.005	0.994	0.000
C62.1 Descended testis	0.005	0.994	0.000
D02.0 Larynx	0.005	0.994	0.000
C41.9 Bone and articular cartilage, unspecified	0.005	0.994	0.000
C41.8 Overlapping lesion of bone and articular cartilage	0.005	0.994	0.000
C41.3 Ribs, sternum and clavicle	0.005	0.994	0.000
C41.2 Vertebral column	0.005	0.994	0.000
C74.9 Adrenal gland, unspecified	0.005	0.995	0.000
H18.8 Other specified disorders of cornea	0.005	0.995	0.000
C69 Malignant neoplasm of eye and adnexa	0.005	0.995	0.000
C41.0 Bones of skull and face	0.005	0.995	0.000
K82.9 Disease of gallbladder, unspecified	0.005	0.995	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.005	0.995	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.005	0.995	0.000
C73 Malignant neoplasm of thyroid gland	0.005	0.995	0.000
C62.0 Undescended testis	0.005	0.995	0.000
C42.4 hematopoietic and reticuloendothelial systems: Hematopoietic system, NOS (ICD-O-3 specific)	0.005	0.995	0.000
C42.3 hematopoietic and reticuloendothelial systems: Reticuloendothelial system, NOS (ICD-O-3 specific)	0.005	0.995	0.000
C42.2 hematopoietic and reticuloendothelial systems: spleen (ICD-O-3 specific)	0.005	0.995	0.000
C42.1 hematopoietic and reticuloendothelial systems: bone marrow (ICD-O-3 specific)	0.005	0.995	0.000
C42.0 hematopoietic and reticuloendothelial systems: blood (ICD-O-3 specific)	0.005	0.995	0.000
D09 Carcinoma in situ of other and unspecified sites	0.005	0.995	0.000
C40.9 Bone and articular cartilage of limb, unspecified	0.005	0.995	0.000
C40.8 Overlapping lesion of bone and articular cartilage of limbs	0.005	0.995	0.000
C40.3 Short bones of lower limb	0.005	0.995	0.000
C40.1 Short bones of upper limb	0.005	0.995	0.000
C40.0 Scapula and long bones of upper limb	0.005	0.995	0.000
C74.1 Medulla of adrenal gland	0.005	0.995	0.000
C74.0 Cortex of adrenal gland	0.005	0.995	0.000
Q44.6 Cystic disease of liver	0.005	0.995	0.000
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.005	0.995	0.000
C60 Malignant neoplasm of penis	0.005	0.995	0.000
C51 Malignant neoplasm of vulva	0.005	0.995	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.005	0.995	0.000
C70 Malignant neoplasm of meninges	0.005	0.995	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.005	0.995	0.000
C75.9 Endocrine gland, unspecified	0.005	0.995	0.000
C57 Malignant neoplasm of other and unspecified female genital organs	0.005	0.995	0.000
C58 Malignant neoplasm of placenta	0.005	0.995	0.000
C50-C50 Malignant neoplasm of breast	0.005	0.995	0.000
C25.2 Tail of pancreas	0.005	0.995	0.000
Q39 Congenital malformations of oesophagus	0.005	0.995	0.000
C40.2 Long bones of lower limb	0.005	0.995	0.000
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.005	0.995	0.000
D02.4 Respiratory system, unspecified	0.005	0.995	0.000
D02.3 Other parts of respiratory system	0.005	0.995	0.000
D02.2 Bronchus and lung	0.005	0.995	0.000
D02.1 Trachea	0.005	0.995	0.000
C32.0 Glottis	0.005	0.995	0.000
S68.1 Traumatic amputation of other single finger (complete)(partial)	0.000	0.995	0.005
C75.8 Pluriglandular involvement, unspecified	0.005	0.995	0.000
C75.5 Aortic body and other paraganglia	0.005	0.995	0.000
C75.4 Carotid body	0.005	0.995	0.000
C75.3 Pineal gland	0.005	0.995	0.000
C75.2 Craniopharyngeal duct	0.005	0.995	0.000
C75.1 Pituitary gland	0.005	0.995	0.000
C75.0 Parathyroid gland	0.005	0.995	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations